On ECHEMI
Home > Drugs > Alzheimer’s dementia
Alzheimer’s dementia
Dementia in Alzheimer’s disease is a progressive neurodegenerative disease with an insidious onset. Clinically, it is characterized by comprehensive dementia manifestations such as memory impairment, aphasia, apraxia, agnosia, visual-spatial skill impairment, executive dysfunction, and personality and behavioral changes. The cause is still unknown. In the past, patients who developed the disease before the age of 65 were called presenile dementia, and patients who developed the disease after the age of 65 were called senile dementia. The main pathological changes of this disease are cerebral cortical atrophy, neurofibrosis, brain nerve cell degeneration and senile plaques. It is a common disease in the elderly.
  • Site of disease:

    Brain
  • Infectious :

    Not contagious
  • Frequent population:

    Elderly population
  • Related symptoms:

    Memory impairment disorientation visual-spatial impairment speech disorder visual agnosia
Related Drugs
Aniracetam Capsules
Indication: 1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in the middle-aged and elderly.
Manufacturer:

Wuxi Cathy Pharmaceuticals Ltd.

Aniracetam Granules
Indication: Brain function improving drug used to treat memory loss after cerebrovascular disease and memory loss in middle-aged and elderly people.
Manufacturer:

Lunan BETTER Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.